Publication stageIn Press Journal Pre-Proof
Conflicts of interest:
Dr. Gottlieb is an advisor/consultant for Janssen Inc., Celgene, Beiersdorf, BMS, Abbvie, UCB, Novartis, Incyte Corporation, Lilly, Reddy Labs, Valeant, Dermira, Allergan, Sun Pharmaceutical Industries, XBiotech, Leo, Avotres Therapeutics, Boeringer Ingelheim. She received research/educational grants from Janssen, Incyte Corporation, XBiotech, Novartis, Boeringer Ingelheim and UCB. In addition, she participated in the development of the National Psoriasis Foundation Psoriasis Score (NPF-PS), an instrument discussed in the present study. Dr. Duffin has served on the advisory board/consultant/investigator for Stiefel, Novartis, Amgen, Abbvie, Celgene, Lilly, Ortho, Pfizer, Janssen and Boehringer Ingelheim. In addition, she has participated in validation studies of the IGAxBSA, an instrument discussed in the present study. Dr. Merola has served as a consultant/investigator/advisory board for Merck, AbbVie Eli Lilly, Incyte, Janssen, UCB, GlaxoSmithKline, Almirall, Pfizer, Sun Pharma, Novartis, Burrage Capital Mgmt, Aclaris, Leo, Celgene, Dermavent.
Dr. Van Beek, Dr. Margo Reeder, Dr. Swerlick, Dr. Perez-Chada and Dr. Taliercio did not report relevant financial conflicts
International Dermatology Outcome Measures (IDEOM) and the American Academy of Dermatology (AAD) have provided financial support for this initiative.
IRB approval: Not required
Reprint requests: none